OPKO Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on March 18, 2013. The report discloses a specific corporate governance event regarding executive compensation approved by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event rather than a periodic financial statement.
Material Changes
On March 18, 2013, the Compensation Committee granted stock options to the Company's named executive officers. The specific grants are as follows:
- Phillip Frost, M.D. (CEO & Chairman of the Board): 500,000 shares
- Jane H. Hsiao (Vice Chairman & Chief Technical Officer): 450,000 shares
- Steven D. Rubin (Executive Vice President - Administration): 450,000 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the exercise price and vesting schedule for the 1,400,000 total stock options granted to executives.
- Review the Company's most recent 10-K or 10-Q to assess the dilution impact of these grants on existing shareholders.
- Confirm if these grants were part of a pre-approved annual equity incentive plan or a special one-time grant.